Showing results (41-50 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|July 4, 2015
Ibrutinib for the treatment of Waldenström macroglobulinemiaRajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, et al.Expert Review of Hematology|June 4, 2015
Bone morbidity in chronic myeloproliferative neoplasmsSarah Farmer, Lukas Frans Ocias, Hanne Vestergaard, et al.Expert Review of Hematology|October 27, 2017
Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemiaMarlise R Luskin, Daniel J DeAngeloExpert Review of Hematology|March 28, 2018
Anti-CD38 and anti-SLAMF7: the future of myeloma immunotherapyElena Zamagni, Paola Tacchetti, Lucia Pantani, et al.Expert Review of Hematology|February 9, 2018
The multiple myeloma treatment landscape: international guideline recommendations and clinical practice in EuropeMichele Cavo, Evangelos Terpos, Joan Bargay, et al.Expert Review of Hematology|March 3, 2018
Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemiaFrancesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, et al.Expert Review of Hematology|February 21, 2018
Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemiaNeil E Kay, Betsy R LaPlant, Adam M Pettinger, et al.Expert Review of Hematology|November 22, 2017
A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemiaTamar Tadmor, Manfred Welslau, Iwona HusExpert Review of Hematology|May 4, 2021
An evaluation of isatuximab, pomalidomide and dexamethasone for adult patients with relapsed and refractory multiple myelomaAnna Piggin, H Miles PrinceExpert Review of Hematology|May 5, 2021
Real-world comparison of direct-acting oral anticoagulants and vitamin K antagonists in chronic kidney disease: a systematic review and meta-analysisRongfang Xu, Fan Wu, Jiarong Lan, et al.Pageof 157